Education and Experience
- University of Illinois College of Medicine (Chicago IL)/ (1985)
- The Johns Hopkins Hospital (Baltimore MD)/ Neurology (1989)
- Neurology, American Board of Psychiatry & Neurology (1990)
Neurology - Neuromuscular
- ALS Clinic
- Muscular Dystrophy Clinic
- Robert Packard Center for ALS Research
His laboratory includes more than 20-post doctoral fellows, neurology residents, neuromuscular and epilepsy fellows, undergraduate students, technicians and ALS clinic staff. He has been the principal and/or local investigator in eight national or international trials in ALS. He is the author of more than 100 articles on basic and clinical neuroscience. Dr. Rothsteins laboratory research is funded through the National Institutes of Health, the Muscular Dystrophy Association, the ALS Association and Project A.L.S.
Dr. Jeffrey Rothstein received a masters degree in neurochemistry from the University of Chicago and a Ph.D. in physiology and biophysics from the University of Illinois Health Sciences Center. He then obtained his medical degree from the University of Illinois College of Medicine. He went on to complete an internship at the University of North Carolina Memorial Hospital before joining The Johns Hopkins for his residency. While at Johns Hopkins, he became chief resident in neurology and completed his fellowship in neuromuscular disease.
- Amyotrophic Lateral Sclerosis
- Lou Gehrig's Disease
- Neuromuscular Disease
- Cloning and characterization of novel proteins which may be responsible for the cellular regulation of glutamate transporters.
- Basic biology of glutamate transporters and their role in acute and chronic neuronal degeneration (e.g. ALS, epilepsy, stroke, spinocerebellar ataxia)
- Models of motor axon regeneration regrowth
- Use of neuronal and non-neuronal stem cell therapies to treat motor neurons diseases including ALS and Spinal Muscular Atrophy
- Identification of novel drug or peptide therapeutics to delay or prevent motor neuron degeneration in ALS through the use of cell culture and transgenic models of ALS
- Various molecular mechanisms of selective neurodegeneration in motor neuron diseases such as amyotrophic lateral sclerosis
- Novel therapeutics in ALS